These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 2497686)
21. A summary of the current position of TRH in ALS therapy. Brooks BR Ann N Y Acad Sci; 1989; 553():431-61. PubMed ID: 2497685 [TBL] [Abstract][Full Text] [Related]
23. Is thyrotropin releasing hormone an endogenous ergotropic substance in the brain? Metcalf G; Dettmar PW Lancet; 1981 Mar; 1(8220 Pt 1):586-9. PubMed ID: 6110823 [TBL] [Abstract][Full Text] [Related]
24. Short-term stability of single motor unit recordings in motor neuron disease: a macro EMG study. Guiloff RJ; Modarres-Sadeghi H; Stålberg E; Rogers H J Neurol Neurosurg Psychiatry; 1988 May; 51(5):671-6. PubMed ID: 3136230 [TBL] [Abstract][Full Text] [Related]
25. Sustained rises in serum thyrotropin, thyroxine, and triiodothyronine during long term, continuous thyrotropin-releasing hormone treatment in patients with amyotrophic lateral sclerosis. Kaplan MM; Taft JA; Reichlin S; Munsat TL J Clin Endocrinol Metab; 1986 Oct; 63(4):808-14. PubMed ID: 3091628 [TBL] [Abstract][Full Text] [Related]
26. [Effect of thyroliberin treatment on the thyrotropin and prolactin levels in patients with amyotrophic lateral sclerosis]. Klimek A; Szulc-Kuberska J; Stepień H Neurol Neurochir Pol; 1990; 24(1-2):31-6. PubMed ID: 2132051 [TBL] [Abstract][Full Text] [Related]
30. [Clinical, electrophysiologic and endocrine effects of the perfusion of high doses of TRH in amyotrophic lateral sclerosis]. Gueguen B; Puymirat J; Grouselle D; Piketty ML; Bleton JP; Bourdel MC; Rondot P Rev Neurol (Paris); 1988; 144(11):704-9. PubMed ID: 3148186 [TBL] [Abstract][Full Text] [Related]
31. Thyrotrophin-releasing hormone. New applications in the clinic. Griffiths EC Nature; 1986 Jul 17-23; 322(6076):212-3. PubMed ID: 3090448 [No Abstract] [Full Text] [Related]
32. The therapeutic potential of thyrotropin releasing hormone (TRH) in Alzheimer's disease (AD). Yarbrough GG; Pomara N Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(3):285-9. PubMed ID: 3929331 [TBL] [Abstract][Full Text] [Related]
33. Protirelin (thyrotropin-releasing hormone) in amyotrophic lateral sclerosis. The role of androgens. Miller SC; Warnick JE Arch Neurol; 1989 Mar; 46(3):330-5. PubMed ID: 2563937 [TBL] [Abstract][Full Text] [Related]
34. [Treatment of motor neuron diseases using intrathecal TRH. Pilot study I]. Patrignani Ochoa J; Morales Martínez D; Martínez Parra C Neurologia; 1988; 3(6):221-5. PubMed ID: 3152558 [No Abstract] [Full Text] [Related]
35. Use of TRH analogues in motorneurone disease. Guiloff RJ Ann N Y Acad Sci; 1989; 553():399-421. PubMed ID: 2497683 [TBL] [Abstract][Full Text] [Related]
36. Thyrotropin-releasing hormone in ALS. Are the results of clinical studies inconsistent? Brooke MH Ann N Y Acad Sci; 1989; 553():422-30. PubMed ID: 2497684 [TBL] [Abstract][Full Text] [Related]
37. Prolactin response to growth hormone-releasing hormone during chronic thyrotropin-releasing hormone infusion in the treatment of amyotrophic lateral sclerosis. Chiodini PG; Attanasio R; Liuzzi A; Cozzi R; Orlandi P; De Palo C; Dallabonzana D; Girotti F; Testa D J Endocrinol Invest; 1990 Sep; 13(8):631-6. PubMed ID: 2125610 [TBL] [Abstract][Full Text] [Related]
39. Effect on weakness and spasticity in amyotrophic lateral sclerosis of thyrotropin-releasing hormone. Engel WK; Siddique T; Nicoloff JT Lancet; 1983 Jul; 2(8341):73-5. PubMed ID: 6134961 [TBL] [Abstract][Full Text] [Related]
40. Prolonged intrathecal infusion of thyrotropin releasing hormone in amyotrophic lateral sclerosis. Munsat TL; Taft J; Kasdon D; Jackson IM Ann N Y Acad Sci; 1988; 531():187-93. PubMed ID: 3132882 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]